OSTEOSARCOMA RECURRENT
Clinical trials for OSTEOSARCOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OSTEOSARCOMA RECURRENT trials appear
Sign up with your email to follow new studies for OSTEOSARCOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo aims to stop bone Cancer's return
Disease control OngoingThis study tests two drugs—nivolumab alone or with azacitidine—in people whose osteosarcoma (a type of bone cancer) has come back and can be surgically removed. The goal is to see if the treatment is safe and helps keep the cancer from returning after surgery. About 21 adults and…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 09:30 UTC
-
New combo therapy shows promise for tough bone cancer
Disease control OngoingThis study tests a combination of two drugs (regorafenib and nivolumab) in people with osteosarcoma, a type of bone cancer, that has returned or not responded to prior treatment. The goal is to see if this combination can stop the cancer from growing for at least 4 months longer …
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 26, 2026 09:29 UTC
-
New drug combo targets tough bone cancer in teens and young adults
Disease control OngoingThis study tests whether combining two drugs, olaparib and ceralasertib, can help control osteosarcoma that has come back or not responded to treatment. About 63 people aged 12 to 40 with this rare bone cancer will take part. The goal is to see if the combination can stop the can…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 09:28 UTC